Mustang Bio
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Mustang Bio and other ETFs, options, and stocks.About MBIO
Mustang Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the translation of medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline includes CAR T therapies for hematologic malignancies, CAR T therapies for solid tumors, and gene therapies for rare genetic disorders.
CEOManuel Litchman
CEOManuel Litchman
Employees6
Employees6
HeadquartersWaltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded2015
Founded2015
Employees6
Employees6
MBIO Key Statistics
Market cap7.37M
Market cap7.37M
Price-Earnings ratio-0.80
Price-Earnings ratio-0.80
Dividend yield—
Dividend yield—
Average volume83.63K
Average volume83.63K
High today$1.04
High today$1.04
Low today$0.97
Low today$0.97
Open price$1.04
Open price$1.04
Volume140.80K
Volume140.80K
52 Week high$21.95
52 Week high$21.95
52 Week low$0.8926
52 Week low$0.8926
Stock Snapshot
As of today, Mustang Bio(MBIO) shares are valued at $1.01. The company's market cap stands at 7.37M, with a P/E ratio of -0.80.
During the trading session on 2025-12-28, Mustang Bio(MBIO) shares reached a daily high of $1.04 and a low of $0.97. At a current price of $1.01, the stock is +4.1% higher than the low and still -2.9% under the high.
Trading volume for Mustang Bio(MBIO) stock has reached 140.8K, versus its average volume of 83.63K.
The stock's 52-week range extends from a low of $0.89 to a high of $21.95.
The stock's 52-week range extends from a low of $0.89 to a high of $21.95.
People also own
Based on the portfolios of people who own MBIO. This list is generated using Robinhood data, and it’s not a recommendation.